Related Experiment Video
Updated: Jan 20, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
Multiomics analyses prioritize disease genes and pathways in hidradenitis suppurativa
Bryan L Peacker1, Liana Ly2, Jonathan C Hwang3
1Harvard Medical School, Boston, Massachusetts, USA; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA; Dermatology Section, VA Boston Healthcare System, Jamaica Plain, Massachusetts, USA.
None:
Hidradenitis suppurativa is a chronic inflammatory skin condition associated with an increased risk of all-cause mortality. Although it is known to be influenced by genetic and environmental factors, the genetic contributors remain poorly characterized. We performed a large-scale meta-analysis involving patients from the Million Veteran Program, UK Biobank, and FinnGen, including a total of 3941 cases and 1,435,603 controls. We identified 9 genome-wide significant loci, 5 of which have not been previously reported. Using a variant-to-gene analysis pipeline, we mapped these variants to 11 lead genes, supporting prior candidates while revealing previously unreported ones, to our knowledge, including SMPD4 and PSMA4, which we demonstrate are differentially expressed in hidradenitis suppurativa skin lesions. Using expression quantitative trait loci and protein quantitative trait loci, 2-sample Mendelian randomization identified additional genes likely involved in the pathogenesis of hidradenitis suppurativa, including MPO. We subsequently probed the protein interactome network of these candidates to reveal drug targets for prioritization in future studies. These results reaffirm the previously suspected role of KLF5 in hidradenitis suppurativa while linking the pathogenesis of the disease to pathways related to lipid and skin barrier homeostasis, proteasome function, and oxidative stress.
Related Concept Videos
03:08Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
10:12The MPLEx Protocol for Multi-omic Analyses of Soil Samples
08:51Application of Unsupervised Multi-Omic Factor Analysis to Uncover Patterns of Variation and Molecular Processes Linked to Cardiovascular Disease
05:01A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
07:35A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
11:00Microfluidic Chip for Axonal Injury Models Construction and Enabling Multi-Omics Analysis

